Treat prostate cancer without surgery or radiation therapy in just one day with FOCAL ONE HIFU.
Preserve your prostate, normal sexual and urinary function!
FOCAL ONE HIFU is the most precise robotic method of non-surgical treatment of prostate cancer that does not imply radiation therapy. The technology does not affect neighboring tissue or other organs. HIFU destroys prostate cancer with precise ultrasound waves aimed specifically at the damaged prostate tissue, using ultrasound energy rather than radiation.
Here are the benefits of localized prostate cancer treatment with Focal One HIFU:
- No incisions (non-invasive method),
- No surgical risks,
- No radiation therapy,
- No lifestyle changes,
- Lowest risk of erectile dysfunction and urinary incontinence,
- Short period of hospitalization,
- Precise focus on the affected prostate tissue,
- Robotic device,
- Healthy tissue remains intact.
The latest FOCAL ONE robotic device (manufactured by EDAP TMS) is a global innovation: it was approved by the FDA just in 2018. Leading U.S. medical centers such as Cleveland Clinic and University of California purchased the device in late 2020.
Keeping in mind the increasing number of requests and the interest demonstrated by foreign patients, the Urology Hub of Professor Guram Karazanashvili offers the most convenient FOCAL ONE HIFU treatment packages.
MMT Hospital, the world’s leader in early diagnosis and treatment of prostate cancer, is the foremost healthcare institution committed to continuous implementation and development of state-of-the-art technologies for the benefit of its patients.